Back to search

Article

RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancer

2021-02-12

Abstract excerpt

Pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is correlated with better outcomes for breast cancer, especially for triple negative breast cancer (TNBC). We developed RNA expression classifiers from a model of breast epithelial cell organization to predict which patients will achieve pCR to NAC, and which will have residual disease (RD). An exclusive collection of retrospective formalin-fix...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3cc04f7-0cae-5829-98dd-bc2412b6ad71
DOI
10.1101/2021.02.10.21251517
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RNA expression classifiers from a model of breast epithelial cell organization to predict pathological complete response in triple negative breast cancerDOI 10.1101/2021.02.10.21251517
The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity
Transcriptome Analysis Derives a Novel Prognostic 7-mRNA Signature in Early-Stage Triple-Negative Breast CancerSemantic proximity
The analysis of transcriptomic signature of TNBC – searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivitySemantic proximity
Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity
FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity
Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity
Malignant cell related gene signature for patients with triple-negative breast cancer based on integrated analysis of single cell and bulk RNA sequencingSemantic proximity
Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancerSemantic proximity
Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast CancerSemantic proximity
Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant ChemotherapySemantic proximity
Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancerSemantic proximity
A novel gene signature to predict response to neoadjuvant chemotherapy and endocrine treatment in estrogen receptor-positive breast cancer patientsSemantic proximity
Select a neighboring publication to make it the new centre.